Syncona Shs GBP (GB:SYNC) has released an update.
Syncona Limited has announced that Dr. Kemal Malik has joined the board of directors of Cartesian Therapeutics, Inc, effective 1st July 2024. Syncona, a company dedicated to investing in life science businesses, aims to enhance human life by developing treatments for areas with high unmet needs. Their strategy involves building a diversified portfolio of leading global life science companies, focusing on long-term outcomes and delivering strong returns to shareholders.
For further insights into GB:SYNC stock, check out TipRanks’ Stock Analysis page.
